A large, rare disease global biopharmaceutical company that is dedicated to finding solutions to help patients living with rare diseases implements additional RxLogix PV systems - RxlogixA large, rare disease global biopharmaceutical company that is dedicated to finding solutions to help patients living with rare diseases implements additional RxLogix PV systems - Rxlogix
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
A large, rare disease global biopharmaceutical company that is dedicated to finding solutions to help patients living with rare diseases implements additional RxLogix PV systems
A large, rare disease global biopharmaceutical company that is dedicated to finding solutions to help patients living with rare diseases implements additional RxLogix PV systems
15 Apr 2022
It was a large project that included the following key systems and capabilities:
PV Quality – New system implementation to monitor the PV case quality
PV Reports Upgrade
Implementation of Reporting Rate calculations in disproportionality algorithms based on imported drug sales/patient exposure data
EVDAS auto-download utility
PV Reports Japan – Two new reports (NUPR, SLL)
Tech: Upgrade of Oracle 12C to Oracle 19C
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.